Results 61 to 70 of about 6,777 (132)

SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase. [PDF]

open access: yesNat Commun, 2022
Higgins CB   +6 more
europepmc   +1 more source

Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity. [PDF]

open access: yesCell Res, 2022
Yao H   +20 more
europepmc   +1 more source

Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4. [PDF]

open access: yesJ Biol Chem, 2022
Gasparrini M   +11 more
europepmc   +1 more source

Nicotinamide phosphoribosyltransferase inhibitors, design, preparation and SAR.

open access: yes, 2013
Existing pharmacological inhibitors for nicotinamide phosphoribosyltransferase (NAMPT) are promising therapeutics for treating cancer. Using medicinal and computational chemistry methods, the structure-activity relationship for novel classes of NAMPT inhibitors is described and compounds optimized. Compounds are designed inspired by the NAMPT inhibitor
Christensen, Mette Knak   +13 more
openaire   +1 more source

Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer Therapy. [PDF]

open access: yesJ Med Chem
Galli U   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy